Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 158

Anaveon validates Novartis for series A

Zurich immuno-oncology spinout Anaveon raised $35.1m from Novartis Venture Fund and Syncona in addition to seed-stage notes converted by the UZH Life Sciences Fund.

Feb 27, 2019

FreightWaves navigates $20m series B round

The freight market commentary provider has increased its overall funding to approximately $40m following a series B round that included corporate venturing units of Hearst and Prologis.

Feb 27, 2019

90 Seconds times $20m series B

The Opt and SKY TV NZ-backed video production platform has collected series B financing from investors including Susquehanna International Group.

Feb 26, 2019

Home Depot helps courier $37m to Roadie

Home Depot has taken part in a $37m series C round, which increased the UPS-backed courier service's overall funding to $62m.

Feb 26, 2019

RapidAPI interfaces with Microsoft for $25m

Microsoft’s M12 unit has participated in a $25m funding round for RapidAPI, with existing investor Andreessen Horowitz also returning.

Feb 26, 2019

Circle Media Labs connects to $20m series B

NetGear and T-Mobile have taken part in the connected device technology startup's $20m series B round, investing alongside Third Venture Capital and Relay Ventures.

Feb 25, 2019

Lytics nabs $35m in series C round

Comcast Ventures has taken part in the JMI-led round, which increased the digital marketing platform's overall funding to more than $58m.

Feb 25, 2019

Ctrl-Labs senses GV in $28m funding round

The neural interface-tracking technology developer has increased its overall funding to $67m following a GV-led funding round that included Amazon's Alexa Fund.

Feb 25, 2019

Ajisen Ramen pays another visit to Yunnex

Fast food retailer Ajisen Ramen reinvested in the smart point-of-sale device provider in a $20m series B-plus round led by Hezhi Investment.

Feb 22, 2019

Calypso Biotech dances through series A round

Merck Group and Johnson & Johnson both invested in a $22.6m round for the autoimmune disease drug developer, six years after it was spun off from Merck Serono.

Feb 22, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here